Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination
- PMID: 32394881
- PMCID: PMC7356443
- DOI: 10.4269/ajtmh.19-0817
Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination
Abstract
Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and hepatocellular carcinoma. To eliminate HCV infection in an endemic area, an epidemiological baseline of the current HCV infection in the population is required. We therefore aimed to evaluate the HCV burden in the Thai Province of Phetchabun, which has the highest HCV infection rate in the country. Toward this, a province-wide district-based representative sampling of 4,769 individuals ages 35-64 years previously shown to represent high-risk age-groups were tested for anti-HCV antibodies using the automated chemiluminescent microparticle assays. Active HCV infection and subsequent genotyping were determined from serologically reactive samples by amplification of the HCV core gene. We found that 6.9% (327/4,769) were anti-HCV positive, of which 75.8% (248/327) had detectable HCV RNA and 5.8% (19/327) were in the presence of hepatitis B virus coinfection. Nucleotide sequencing and phylogenetic analysis revealed that HCV genotype 6 was the most prevalent (41%, 101/248), followed by genotype 3 (31%, 78/248), and genotype 1 (28%, 69/248). Socioeconomic and demographic factors including male gender, education, and agricultural work were associated with HCV seropositivity. From these results, we defined the regional HCV genotypes and estimated the HCV burden necessary toward the implementation of pan-genotypic direct-acting antivirals, which may be appropriate and effective toward the diversity of genotypes identified in this study. Micro-elimination of HCV in Phetchabun may serve as a model for a more comprehensive coverage of HCV treatment in Thailand.
Figures


Similar articles
-
Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand.PLoS One. 2023 Jan 19;18(1):e0268728. doi: 10.1371/journal.pone.0268728. eCollection 2023. PLoS One. 2023. PMID: 36656832 Free PMC article.
-
Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.J Med Virol. 2008 Feb;80(2):268-76. doi: 10.1002/jmv.21057. J Med Virol. 2008. PMID: 18098133
-
Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.PLoS One. 2015 May 11;10(5):e0126764. doi: 10.1371/journal.pone.0126764. eCollection 2015. PLoS One. 2015. PMID: 25962112 Free PMC article.
-
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.Expert Opin Pharmacother. 2014 Jul;15(10):1337-49. doi: 10.1517/14656566.2014.913571. Epub 2014 Apr 29. Expert Opin Pharmacother. 2014. PMID: 24773464 Review.
-
Literature review of the distribution of hepatitis C virus genotypes across Europe.J Med Virol. 2016 Dec;88(12):2157-2169. doi: 10.1002/jmv.24573. Epub 2016 Jul 11. J Med Virol. 2016. PMID: 27171396 Review.
Cited by
-
Molecular Epidemiology of Hepatitis C Virus Genotypes in Northern Thailand: A Retrospective Study from 2016 to 2024.Infect Dis Rep. 2025 Jun 23;17(4):73. doi: 10.3390/idr17040073. Infect Dis Rep. 2025. PMID: 40700320 Free PMC article.
-
Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.BMC Infect Dis. 2021 Feb 26;21(1):223. doi: 10.1186/s12879-021-05826-0. BMC Infect Dis. 2021. PMID: 33637051 Free PMC article.
-
Real-world treatment outcomes of sofosbuvir-based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co-infection.JGH Open. 2023 Jan 26;7(2):157-162. doi: 10.1002/jgh3.12869. eCollection 2023 Feb. JGH Open. 2023. PMID: 36852142 Free PMC article.
-
Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey.BMC Infect Dis. 2022 Feb 22;22(1):177. doi: 10.1186/s12879-022-07163-2. BMC Infect Dis. 2022. PMID: 35193496 Free PMC article.
-
Population and transmission dynamics model to determine WHO targets for eliminating Hepatitis C virus in Thailand.PLoS One. 2024 Oct 16;19(10):e0309313. doi: 10.1371/journal.pone.0309313. eCollection 2024. PLoS One. 2024. PMID: 39413060 Free PMC article.
References
-
- Polaris Observatory HCV Collaborators , 2017. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2: 161–176. - PubMed
-
- Thomas DL, 2019. Global elimination of chronic hepatitis. N Engl J Med 380: 2041–2050. - PubMed
-
- World Health Organization , 2016. Combating Hepatitis B and C to Reach Elimination by 2030. Available at: https://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief.... Accessed October 30, 2019.
-
- Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H, 2014. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61 (Suppl 1): S45–S57. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical